Back to PFE Stock Lookup

Pfizer (PFE) – Press Releases

Sep 28, 2016 08:50 AM Pfizer Completes Acquisition of Medivation
Sep 28, 2016 06:00 AM Pfizer to Showcase Progress of Broad-Based Oncology Portfolio at European Society for Medical Oncology (ESMO) 2016 Congress
Sep 26, 2016 06:45 AM Pfizer Decides Remaining One Company Best Positions Company To Maximize Future Value Creation
Sep 23, 2016 08:30 AM Pfizer Announces Expiration of HSR Waiting Period For Proposed Acquisition of Medivation
Sep 22, 2016 11:56 AM Pfizer Declares 30-Cent Fourth-Quarter 2016 Dividend
Sep 20, 2016 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of November 1 Conference Call With Analysts
Sep 16, 2016 05:24 PM Pfizer Announces Positive Top-Line Results from REFLECTIONS B537-02 Study for PF-06438179 (infliximab-Pfizer) a Potential Biosimilar to Remicade® (infliximab)
Sep 16, 2016 07:24 AM Pfizer Receives Positive CHMP Opinion For IBRANCE® (palbociclib) In Combination With Endocrine Therapy For The Treatment Of HR+/HER2- Metastatic Breast Cancer In Europe
Sep 15, 2016 09:00 AM OncoImmune Announces Option and License Agreement with Pfizer Inc.
Sep 15, 2016 08:31 AM Merck and Pfizer Announce Investigational Ertugliflozin Met Primary Endpoint of A1C Reduction When Added to Sitagliptin and Metformin in People with Type 2 Diabetes
Sep 14, 2016 06:14 PM FDA Advisory Committees Recommend to Remove Boxed Warning in Labeling for Pfizer’s Smoking Cessation Therapy, CHANTIX® (varenicline)
Sep 13, 2016 10:00 AM Pfizer Launches New “Moodivator” App to Help Support, Encourage and Motivate People with Depression
Sep 12, 2016 08:00 AM Circle Pharma Enters into an Agreement with Pfizer to Build Screening Library of Macrocyclic Peptides
Sep 8, 2016 09:07 AM AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics
Sep 8, 2016 09:07 AM AnTolRx, Inc. Announces Series A Equity Funding from Pfizer, JDRF and Orion Equity Partners, LLC to Develop Targeted Nanoparticle Tolerance Therapeutics
Sep 7, 2016 08:00 AM Pfizer Appoints Chief Scientific Officer for Neuroscience Research
Sep 6, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Morgan Stanley Global Healthcare Conference
Sep 1, 2016 10:00 AM Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Aug 31, 2016 07:00 AM XALKORI® (Crizotinib) Receives Approval In European Union For The Treatment Of Patients With ROS1-Positive Advanced Non-Small Cell Lung Cancer
Aug 24, 2016 02:00 AM Pfizer to Acquire Small Molecule Anti-Infective Business from AstraZeneca
Aug 23, 2016 06:59 AM Bristol-Myers Squibb and Pfizer to Present New Eliquis (apixaban) Analyses at ESC Congress 2016
Aug 22, 2016 06:46 AM Pfizer to Acquire Medivation
Aug 22, 2016 06:45 AM Pfizer To Acquire Medivation
Aug 19, 2016 06:21 PM FDA Approves TROXYCA® ER (oxycodone hydrochloride and naltrexone hydrochloride) Extended-Release Capsules CII with Abuse-Deterrent Properties for the Management of Pain
Aug 16, 2016 08:55 AM ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment
Aug 8, 2016 08:00 AM Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease
Aug 4, 2016 04:05 PM Hercules Announces Strong Second Quarter Financial Results with $0.32 NII per Share and a $0.31 Quarterly Dividend
Aug 2, 2016 06:45 AM PFIZER REPORTS SECOND-QUARTER 2016 RESULTS
Aug 1, 2016 10:00 AM Pfizer Aims to Become Industry Leader in Gene Therapy with Acquisition of Bamboo Therapeutics, Inc.
Jul 28, 2016 04:10 PM Pfizer Announces Positive Top-Line Results from Pivotal Phase 3 Maintenance Trial of Oral XELJANZ® (Tofacitinib Citrate) in Ulcerative Colitis
Jul 28, 2016 10:00 AM Pfizer and Western Oncolytics Announce Immuno-Oncology Research Collaboration to Investigate Novel Oncolytic Virus Technology
Jul 26, 2016 05:27 PM BIND Therapeutics Determines Pfizer’s $40 Million Bid Is Highest and Best in 363 Auction for Substantially All of BIND’s Assets
Jul 25, 2016 08:30 AM Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2 Trial Demonstrating Consistent, Sustained Therapeutic Levels of Factor IX Activity
Jul 21, 2016 07:30 AM Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001 for the Treatment of Hemophilia B
Jul 19, 2016 08:00 AM Pfizer Receives World Health Organization Prequalification for Multi-Dose Vial Presentation of Prevenar 13®
Jul 18, 2016 06:15 AM ARIA Study Shows Superior Efficacy of Triumeq® for Treatment-naïve Women Living with HIV
Jul 13, 2016 08:00 AM Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis
Jul 12, 2016 04:04 PM Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
Jul 8, 2016 08:00 AM Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma
Jul 6, 2016 08:00 AM Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jul 6, 2016 08:00 AM Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Jul 5, 2016 11:34 AM Hercules Provides Portfolio Update for Q2 2016 and Highlights Continued Execution of Its Portfolio and Earnings Growth Strategy
Jul 1, 2016 05:30 PM BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer Inc.
Jun 28, 2016 08:30 AM Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results
Jun 27, 2016 11:30 PM Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China
Jun 24, 2016 09:00 AM Pfizer Completes Acquisition of Anacor
Jun 23, 2016 04:00 PM Pfizer Declares 30-Cent Third-Quarter 2016 Dividend
Jun 21, 2016 10:00 AM Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts
Jun 21, 2016 10:00 AM Roger Ulrich Joins Board of Remedy Pharmaceuticals
Jun 16, 2016 09:00 AM Help Pfizer Change The Future Of Healthy Aging

Back to PFE Stock Lookup